Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$1.60
-$0.07-4.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 65.23% | 142.72% | 82.51% | 71.65% | 57.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.43% | 103.33% | 61.58% | 30.61% | 34.61% |
| Operating Income | -51.43% | -103.33% | -61.58% | -30.61% | -34.61% |
| Income Before Tax | -16.53% | -68.75% | -42.43% | -38.71% | -61.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.53% | -68.75% | -42.43% | -38.71% | -61.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.53% | -68.75% | -42.43% | -38.71% | -61.08% |
| EBIT | -51.43% | -103.33% | -61.58% | -30.61% | -34.61% |
| EBITDA | -51.49% | -103.51% | -61.71% | -30.67% | -34.66% |
| EPS Basic | 80.93% | 33.26% | 15.88% | -5.39% | -31.56% |
| Normalized Basic EPS | 79.38% | 41.90% | 18.22% | -2.24% | -32.14% |
| EPS Diluted | 79.15% | 31.14% | 13.91% | -7.51% | -31.56% |
| Normalized Diluted EPS | 79.38% | 41.90% | 18.22% | -2.24% | -32.14% |
| Average Basic Shares Outstanding | 1,056.05% | 457.82% | 148.31% | 53.72% | 22.55% |
| Average Diluted Shares Outstanding | 1,056.05% | 457.82% | 148.31% | 53.72% | 22.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |